{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:11:38Z","timestamp":1781806298838,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"World Scleroderma Foundation and Edith Busch Stiftung","award":["EBF and WSF Research Grant Programme 2022-2023"],"award-info":[{"award-number":["EBF and WSF Research Grant Programme 2022-2023"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["UIDB\/04501\/2020, DOI 10.54499\/UIDB\/04501\/2020, UIDP\/04501\/2020, DOI 10.54499\/UIDP\/04501\/2020"],"award-info":[{"award-number":["UIDB\/04501\/2020, DOI 10.54499\/UIDB\/04501\/2020, UIDP\/04501\/2020, DOI 10.54499\/UIDP\/04501\/2020"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["UIDB\/50011\/2020 (DOI 10.54499\/UIDB\/50011\/2020), UIDP\/50011\/2020 (DOI 10.54499\/UIDP\/50011\/2020) & LA\/P\/0006\/2020 (DOI 10.54499\/LA\/P\/0006\/2020)"],"award-info":[{"award-number":["UIDB\/50011\/2020 (DOI 10.54499\/UIDB\/50011\/2020), UIDP\/50011\/2020 (DOI 10.54499\/UIDP\/50011\/2020) & LA\/P\/0006\/2020 (DOI 10.54499\/LA\/P\/0006\/2020)"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["(LA\/P\/0008\/202, DOI 10.54499\/LA\/P\/0008\/2020; UIDP\/50006\/2020, DOI 10.54499\/UIDP\/50006\/2020; UIDB\/50006\/2020, DOI10.54499\/UIDB\/50006\/2020)"],"award-info":[{"award-number":["(LA\/P\/0008\/202, DOI 10.54499\/LA\/P\/0008\/2020; UIDP\/50006\/2020, DOI 10.54499\/UIDP\/50006\/2020; UIDB\/50006\/2020, DOI10.54499\/UIDB\/50006\/2020)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03500-3","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:36:20Z","timestamp":1739943380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Distinct metabolic profiles of circulating plasmacytoid dendritic cells in systemic sclerosis patients stratified by clinical phenotypes"],"prefix":"10.1186","volume":"27","author":[{"given":"Beatriz H.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mazeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o L.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Arg\u00fcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iola F.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina R.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"3500_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2022","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V. Systemic sclerosis. Lancet. 2022;401:304\u201318.","journal-title":"Lancet"},{"key":"3500_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685\u201399.","journal-title":"Lancet"},{"key":"3500_CR3","doi-asserted-by":"publisher","first-page":"11212","DOI":"10.1038\/s41598-022-15062-4","volume":"12","author":"KEN Clark","year":"2022","unstructured":"Clark KEN, Campochiaro C, Host LV, Sari A, Harvey J, Denton CP, et al. Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes. Sci Rep. 2022;12:11212.","journal-title":"Sci Rep"},{"issue":"11","key":"3500_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"3500_CR5","first-page":"285","volume":"12","author":"IS Silva","year":"2023","unstructured":"Silva IS, Ferreira BH, Almeida CR. Molecular mechanisms behind the role of Plasmacytoid dendritic cells in systemic sclerosis. Biology (Basel). 2023;12:285.","journal-title":"Biology (Basel)"},{"issue":"9","key":"3500_CR6","doi-asserted-by":"publisher","first-page":"e98380","DOI":"10.1172\/jci.insight.98380","volume":"3","author":"S Kafaja","year":"2018","unstructured":"Kafaja S, Valera I, Divekar AA, Saggar R, Abtin F, Furst DE, et al. pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis. JCI Insight. 2018;3(9):e98380.","journal-title":"JCI Insight"},{"key":"3500_CR7","doi-asserted-by":"publisher","first-page":"eaam8458","DOI":"10.1126\/scitranslmed.aam8458","volume":"10","author":"MD Ah Kioon","year":"2018","unstructured":"Ah Kioon MD, Tripodo C, Fernandez D, Kirou KA, Spiera RF, Crow MK, et al. Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Sci Transl Med. 2018;10:eaam8458.","journal-title":"Sci Transl Med"},{"issue":"7","key":"3500_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/annrheumdis-2020-218439","volume":"80","author":"RL Ross","year":"2021","unstructured":"Ross RL, Corinaldesi C, Migneco G, Carr IM, Antanaviciute A, Wasson CW, et al. Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Ann Rheum Dis. 2021;80(7):920\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3500_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Van Bon","year":"2014","unstructured":"Van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370(5):433\u201343.","journal-title":"N Engl J Med"},{"issue":"1","key":"3500_CR10","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","volume":"10","author":"R Lande","year":"2019","unstructured":"Lande R, Lee EY, Palazzo R, Marinari B, Pietraforte I, Santos GS, et al. CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-\u03b1 production in systemic sclerosis. Nat Commun. 2019;10(1):1731.","journal-title":"Nat Commun"},{"issue":"14","key":"3500_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21145102","volume":"21","author":"R Lande","year":"2020","unstructured":"Lande R, Mennella A, Palazzo R, Pietraforte I, Stefanantoni K, Iannace N, et al. Anti-CXCL4 antibody reactivity is present in systemic sclerosis (SSc) and correlates with the SSc type I interferon signature. Int J Mol Sci. 2020;21(14):1\u201316.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3500_CR12","doi-asserted-by":"publisher","first-page":"e20221085","DOI":"10.1084\/jem.20221085","volume":"219","author":"V Chaudhary","year":"2022","unstructured":"Chaudhary V, Ah Kioon MD, Hwang SM, Mishra B, Lakin K, Kirou KA, et al. Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses. J Exp Med. 2022;219(11):e20221085.","journal-title":"J Exp Med"},{"issue":"9","key":"3500_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553\u201365.","journal-title":"Nat Rev Immunol"},{"key":"3500_CR14","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3389\/fimmu.2018.02489","volume":"9","author":"F Basit","year":"2018","unstructured":"Basit F, Mathan T, Sancho D, De Vries JM. Human dendritic cell subsets undergo distinct metabolic reprogramming for immune response. Front Immunol. 2018;9:2489.","journal-title":"Front Immunol"},{"issue":"5","key":"3500_CR15","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.4049\/jimmunol.1501557","volume":"196","author":"G Bajwa","year":"2016","unstructured":"Bajwa G, DeBerardinis RJ, Shao B, Hall B, Farrar JD, Gill MA. Cutting Edge: critical role of glycolysis in human plasmacytoid dendritic cell antiviral responses. J Immunol. 2016;196(5):2004\u20139.","journal-title":"J Immunol"},{"issue":"6","key":"3500_CR16","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","volume":"44","author":"D Wu","year":"2016","unstructured":"Wu D, Sanin DE, Everts B, Chen Q, Qiu J, Buck MD, et al. Type 1 interferons induce changes in Core Metabolism that are critical for Immune function. Immunity. 2016;44(6):1325\u201336.","journal-title":"Immunity"},{"issue":"6","key":"3500_CR17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","volume":"32","author":"RJ Arg\u00fcello","year":"2020","unstructured":"Arg\u00fcello RJ, Combes AJ, Char R, Gigan J-P, Baaziz AI, Bousiquot E, et al. SCENITH: a Flow Cytometry-based method to functionally Profile Energy metabolism with single-cell resolution. Cell Metab. 2020;32(6):1063\u2013e10757.","journal-title":"Cell Metab"},{"issue":"2","key":"3500_CR18","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"3500_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/art.41153","volume":"72","author":"SI Nihtyanova","year":"2020","unstructured":"Nihtyanova SI, Sari A, Harvey JC, Leslie A, Derrett-Smith EC, Fonseca C, et al. Using autoantibodies and cutaneous subset to develop outcome-based Disease classification in systemic sclerosis. Arthritis Rheumatol. 2020;72(3):465\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"3500_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fimmu.2019.00410","volume":"10","author":"Z He","year":"2019","unstructured":"He Z, Zhu X, Shi Z, Wu T, Wu L. Metabolic regulation of dendritic cell differentiation. Front Immunol. 2019;10:410.","journal-title":"Front Immunol"},{"key":"3500_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.12688\/f1000research.11332.2","volume":"6","author":"P Saas","year":"2017","unstructured":"Saas P, Varin A, Perruche S, Ceroi A. Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: potential ways to control these functions. F1000Res. 2017;6:456.","journal-title":"F1000Res"},{"issue":"1","key":"3500_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41467-017-00695-1","volume":"8","author":"A Combes","year":"2017","unstructured":"Combes A, Camosseto V, N\u2019Guessan P, Arg\u00fcello RJ, Mussard J, Caux C, et al. BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells. Nat Commun. 2017;8(1):913.","journal-title":"Nat Commun"},{"issue":"2","key":"3500_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","volume":"32","author":"B Kelly","year":"2020","unstructured":"Kelly B, Pearce EL. Amino assets: how amino acids support immunity. Cell Metab. 2020;32(2):154\u201375.","journal-title":"Cell Metab"},{"issue":"1","key":"3500_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.coi.2009.03.003","volume":"21","author":"P Pierre","year":"2009","unstructured":"Pierre P. Immunity and the regulation of protein synthesis: surprising connections. Curr Opin Immunol. 2009;21(1):70\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"3500_CR25","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1083\/jcb.200707166","volume":"179","author":"H Lelouard","year":"2007","unstructured":"Lelouard H, Schmidt EK, Camosseto V, Clavarino G, Ceppi M, Hsu H-T, et al. Regulation of translation is required for dendritic cell function and survival during activation. J Cell Biol. 2007;179(7):1427\u201339.","journal-title":"J Cell Biol"},{"key":"3500_CR26","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.3389\/fimmu.2018.03070","volume":"9","author":"T Fekete","year":"2018","unstructured":"Fekete T, S\u00fct\u00f6 MI, Bencze D, M\u00e1zl\u00f3 A, Szabo A, Biro T, et al. Human plasmacytoid and monocyte-derived dendritic cells display distinct metabolic Profile upon RIG-I activation. Front Immunol. 2018;9:3070.","journal-title":"Front Immunol"},{"issue":"16","key":"3500_CR27","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1111\/febs.15327","volume":"287","author":"G Soto-Heredero","year":"2020","unstructured":"Soto-Heredero G, G\u00f3mez de las Heras MM, Gaband\u00e9-Rodr\u00edguez E, Oller J, Mittelbrunn M. Glycolysis \u2013 a key player in the inflammatory response. FEBS J. 2020;287(16):3350\u201369.","journal-title":"FEBS J"},{"issue":"1","key":"3500_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1689-6","volume":"20","author":"E Raschi","year":"2018","unstructured":"Raschi E, Chighizola CB, Cesana L, Privitera D, Ingegnoli F, Mastaglio C, et al. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts. Arthritis Res Ther. 2018;20(1):1\u201318.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3500_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13075-020-02360-3","volume":"22","author":"E Raschi","year":"2020","unstructured":"Raschi E, Privitera D, Bodio C, Lonati PA, Borghi MO, Ingegnoli F, et al. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis. Arthritis Res Ther. 2020;22(1):265.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"3500_CR30","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/ard.2009.121400","volume":"69","author":"ML Eloranta","year":"2010","unstructured":"Eloranta ML, Franck-Larsson K, L\u00f6vgren T, Kalamajski S, R\u00f6nnblom A, Rubin K, et al. Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann Rheum Dis. 2010;69(7):1396\u2013402.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3500_CR31","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/art.23486","volume":"58","author":"D Kim","year":"2008","unstructured":"Kim D, Peck A, Santer D, Patole P, Schwartz SM, Molitor JA, et al. Induction of interferon-\u03b1 by scleroderma sera containing autoantibodies to topoisomerase I: Association of higher interferon-\u03b1 activity with lung fibrosis. Arthritis Rheum. 2008;58(7):2163\u201373.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3500_CR32","first-page":"21","volume":"1","author":"R Freitas","year":"2022","unstructured":"Freitas R, Martins P, Dourado E, Santiago T, Guimar\u00e3es F, Fernandes BM, et al. Clinical features and outcome of 1054 patients with systemic sclerosis: analysis of Reuma.pt\/SSc registry. ARP Rheumatol. 2022;1(1):21\u20139.","journal-title":"ARP Rheumatol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03500-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03500-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03500-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T05:36:24Z","timestamp":1739943384000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03500-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3500"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03500-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.27.625448","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants signed an informed consent form before inclusion and clinical data collected were anonymised. This study was approved by the Ethics Committee of Centro Hospitalar do Baixo Vouga (now ULS-RA) (Reference 44-069-2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Rafael J. Arg\u00fcello is scientist and co-founder of GammaOmics, a startup that holds the exclusive license to commercialize and provide services for SCENITH\u2122, a technology utilized in this study. No other conflicts of interest are declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}